Care - Pro Bio Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-12-2024
- Paid Up Capital ₹ 0.75 M
as on 04-12-2024
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -68.49%
(FY 2019)
- Profit -388.33%
(FY 2019)
- Ebitda -311.54%
(FY 2019)
- Net Worth -9.51%
(FY 2019)
- Total Assets -6.90%
(FY 2019)
About Care - Pro Bio Technologies
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.75 M, as per Ministry of Corporate Affairs (MCA) records.
Kshyama Singh and Sitaram Paikray serve as directors at the Company.
- CIN/LLPIN
U73100DL2007PTC165737
- Company No.
165737
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jul 2007
- Date of AGM
10 Jun 2023
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Care - Pro Bio Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kshyama Singh  | Director | 11-Jul-2007 | Current |
| Sitaram Paikray | Director | 10-Jun-2008 | Current |
Financial Performance of Care - Pro Bio Technologies.
Care - Pro Bio Technologies Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 68.49% decrease. The company also saw a substantial fall in profitability, with a 388.33% decrease in profit. The company's net worth dipped by a decrease of 9.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Care - Pro Bio Technologies?
In 2019, Care - Pro Bio Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Care Pro Bioscience Private LimitedActive 19 years 6 monthsKshyama Singh and Sitaram Paikray are mutual person
- International Traceability Systems LimitedActive 18 years 8 months
Kshyama Singh and Sitaram Paikray are mutual person
- Immuno Vitalis Global Private LimitedActive 10 months 1 day
Kshyama Singh and Sitaram Paikray are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Care - Pro Bio Technologies?
Unlock and access historical data on people associated with Care - Pro Bio Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Care - Pro Bio Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Care - Pro Bio Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
